Parkinson s Disease Therapeutics

Parkinson’s Disease Therapeutics: Emphasis on Nanotechnological Advances presents the latest information on the second most common neurodegenerative disorder in the elderly. Despite remarkable progress in various PD therapeutics, such as microRNAs and brain drug delivery systems, a few limitations impede their success. This book sheds light on the pros and cons of recently developed novel therapeutics. Very few books have highlighted the protective efficacy of natural products, antioxidants, and biomaterial design for other diseases. Emphasizes novel therapeutics for Parkinson’s disease, including nanotechnology, natural products and antioxidants Discusses the pros and cons of recently developed therapy options for Parkinson's Focuses on the efficacy of nanotechnology in overcoming the blood-brain barrier and biomaterial design

Produk Detail:

  • Author : Magisetty Obulesu
  • Publisher : Academic Press
  • Pages : 146 pages
  • ISBN : 0128198834
  • Rating : 4/5 from 21 reviews
CLICK HERE TO GET THIS BOOKParkinson s Disease Therapeutics

Parkinson’s Disease Therapeutics

Parkinson’s Disease Therapeutics
  • Author : Magisetty Obulesu
  • Publisher : Academic Press
  • Release : 30 January 2020
GET THIS BOOKParkinson’s Disease Therapeutics

Parkinson’s Disease Therapeutics: Emphasis on Nanotechnological Advances presents the latest information on the second most common neurodegenerative disorder in the elderly. Despite remarkable progress in various PD therapeutics, such as microRNAs and brain drug delivery systems, a few limitations impede their success. This book sheds light on the pros and cons of recently developed novel therapeutics. Very few books have highlighted the protective efficacy of natural products, antioxidants, and biomaterial design for other diseases. Emphasizes novel therapeutics for Parkinson’

Parkinson's Disease Therapeutics

Parkinson's Disease Therapeutics
  • Author : Magisetty Obulesu
  • Publisher : Academic Press
  • Release : 24 January 2020
GET THIS BOOKParkinson's Disease Therapeutics

Parkinson's Disease is the second most common neurodegenerative disorder in the elderly. Vital pathological events include a decline in nigrostriatal neurons and deterioration of the neurotransmitter dopamine. Since amyloid fibrils are the key end products of several proteins implicated in neurodegenerative diseases, multiple studies emphasize their diagnosis as the mainstay of current research. Despite remarkable progress in various PD therapeutics such as microRNAs and brain drug delivery systems, a few limitations impede their success. In addition, nanotechnological therapeutics avenues employed

Parkinson's Disease

Parkinson's Disease
  • Author : Sarat Chandra Yenisetti
  • Publisher : BoD – Books on Demand
  • Release : 30 May 2018
GET THIS BOOKParkinson's Disease

Parkinson's disease (PD) is the second most common neurodegenerative disorder results due to loss of dopamine producing brain cells. Knowledge relating to PD condition has been known since 5000BC, however no effective therapeutic strategies are available till today. Therefore it is important for neurobiologists to work further by taking advantage of modern scientific methods and develop appropriate therapeutic strategies. Efforts in this direction are worthy as they will reduce the burden of PD among elderly, who are already burdened with

Recent Advances in Parkinsons Disease

Recent Advances in Parkinsons Disease
  • Author : Anonim
  • Publisher : Elsevier
  • Release : 20 August 2010
GET THIS BOOKRecent Advances in Parkinsons Disease

This first volume starts with an overview on current perspectives in genetic research and on the molecular mechanisms of neurodegeneration. This is followed by a selection of hot topics in pathophysiological research, from molecular studies to system-level investigations based on in vivo electrophysiological recordings and neurocomputational methods. Complete overview of hot topics and approaches to current PD research, from molecules, to brain circuits, to clinical and therapeutic applications. Leading authors review the state-of-the-art in their field of investigation, and provide

Parkinson's Disease

Parkinson's Disease
  • Author : Patrik Verstreken
  • Publisher : Academic Press
  • Release : 19 December 2016
GET THIS BOOKParkinson's Disease

Parkinson’s Disease: Molecular Mechanisms Underlying Pathology explores the molecular pathways at the basis of the cellular defects connected to Parkinson’s disease, the second most common neurodegenerative disease, and the most common movement disorder. This book presents the latest research on the pathways and mechanisms that have been discovered to play a role in Parkinson's pathology. This focus on mechanisms rather than individual genes allows the contributors to elaborate on overlapping and joint functions of different causative genes. Readers

Atypical Parkinsonian Disorders

Atypical Parkinsonian Disorders
  • Author : Irene Litvan
  • Publisher : Springer Science & Business Media
  • Release : 27 October 2007
GET THIS BOOKAtypical Parkinsonian Disorders

A comprehensive review of what is known not only about the cause and treatment of atypical parksonian disorders, but also the issues that clinicians, researchers, patients, and caregivers face in dealing with them. The authors cover the basic science (history, epidemiology, genetics, pathology, nosology, computer modeling, and animal models), detailed clinical and laboratory assessments, and available diagnostic tools, including neuropsychiatric, neurologic, neuropsychologic, speech, electrophysiologic, and imaging evaluations. Current and future therapeutic approaches are also detailed, along with extensive discussions about

Diagnosis and Management in Parkinson's Disease

Diagnosis and Management in Parkinson's Disease
  • Author : Colin R. Martin,Victor R. Preedy
  • Publisher : Academic Press
  • Release : 13 August 2020
GET THIS BOOKDiagnosis and Management in Parkinson's Disease

Diagnosis and Management in Parkinson's Disease: The Neuroscience of Parkinson’s, Volume 1 provides a single source of material covering different scientific domains of neuropathology underlying this condition. The book covers a wide range of subjects and unravels the complex relationships between genetics, molecular biology, pharmaceutical chemistry, neurobiology, imaging, assessments, and treatment regimens. It fills a much-needed gap as a "one-stop" synopsis of everything concerning the neurology and neuroscience related to Parkinson’s disease, from chemicals and cells to individuals. The

Therapy of Parkinson's Disease

Therapy of Parkinson's Disease
  • Author : Rajesh Pahwa,Kelly E. Lyons,William Koller
  • Publisher : CRC Press
  • Release : 19 April 2004
GET THIS BOOKTherapy of Parkinson's Disease

A comprehensive review of current tactics in the therapeutic management of Parkinson's disease, this volume offers summaries of salient research findings as well as contemporary attitudes and practical advice from field specialists. The well-timed Third Edition is expanded and topically reorganized to register trends and progress in anti-parkinsoni

Fast Facts: Psychosis in Parkinson's Disease

Fast Facts: Psychosis in Parkinson's Disease
  • Author : Joseph H Friedman,Clive Ballard
  • Publisher : Karger Medical and Scientific Publishers
  • Release : 07 May 2019
GET THIS BOOKFast Facts: Psychosis in Parkinson's Disease

Psychosis affects nearly 50% of patients with Parkinson’s disease (PD). It is a major therapeutic challenge, as a balance needs to be found between the PD medications that can exacerbate psychotic symptoms and the antipsychotics that may worsen motor function. Focusing on the most common side effects of PD medications, namely visual hallucinations and delusions, this highly readable handbook will increase readers’ awareness of: • the various presentations of psychosis in PD • modifiable risk factors • prescribing that balances the benefits and

Ending Parkinson's Disease

Ending Parkinson's Disease
  • Author : Ray Dorsey,Todd Sherer,Michael S. Okun,Bastiaan R. Bloem
  • Publisher : PublicAffairs
  • Release : 17 March 2020
GET THIS BOOKEnding Parkinson's Disease

Four top experts provide a plan to help prevent the Parkinson's pandemic, improve care and treatment, and end the silence associated with this devastating disease Brain diseases are now the world's leading source of disability. The fastest growing of these is Parkinson's: the number of people with Parkinson's doubled to over 6 million over the last 25 years and is projected to double again by 2040. Harmful pesticides known to cause Parkinson's proliferate, many people remain undiagnosed and untreated, research funding stagnates, and

Pathology, Prevention and Therapeutics of Neurodegenerative Disease

Pathology, Prevention and Therapeutics of Neurodegenerative Disease
  • Author : Sarika Singh,Neeraj Joshi
  • Publisher : Springer
  • Release : 24 September 2018
GET THIS BOOKPathology, Prevention and Therapeutics of Neurodegenerative Disease

This book, written by a leading panel of experts in the field of neurosciences, provides a comprehensive overview of the pathology of neurodegenerative diseases as well as the preventive measures. Prevention is important due to the lack of early diagnostic markers and the limitations/ problems of treating neurodegenerative diseases

Magnesium in the Central Nervous System

Magnesium in the Central Nervous System
  • Author : Robert Vink,Mihai Nechifor
  • Publisher : University of Adelaide Press
  • Release : 16 May 2021
GET THIS BOOKMagnesium in the Central Nervous System

The brain is the most complex organ in our body. Indeed, it is perhaps the most complex structure we have ever encountered in nature. Both structurally and functionally, there are many peculiarities that differentiate the brain from all other organs. The brain is our connection to the world around us and by governing nervous system and higher function, any disturbance induces severe neurological and psychiatric disorders that can have a devastating effect on quality of life. Our understanding of the